REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $384,451 | -54.1% | 33,518 | +1.2% | 0.00% | -100.0% |
| Q2 2023 | $838,394 | -14.7% | 33,125 | +8.5% | 0.00% | 0.0% |
| Q1 2023 | $983,114 | +74.5% | 30,522 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $563,436 | -24.8% | 30,522 | +10.0% | 0.00% | 0.0% |
| Q3 2022 | $749,169 | +99.8% | 27,747 | +2.2% | 0.00% | 0.0% |
| Q2 2022 | $375,000 | -30.7% | 27,154 | -2.1% | 0.00% | 0.0% |
| Q1 2022 | $541,000 | +19.4% | 27,745 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $453,000 | -40.7% | 27,745 | +1.2% | 0.00% | -50.0% |
| Q3 2021 | $764,000 | -6.0% | 27,418 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $813,000 | +5.0% | 27,418 | -1.0% | 0.00% | 0.0% |
| Q1 2021 | $774,000 | -1.1% | 27,689 | +0.2% | 0.00% | 0.0% |
| Q4 2020 | $783,000 | +48.3% | 27,629 | +31.5% | 0.00% | +100.0% |
| Q3 2020 | $528,000 | +7.8% | 21,010 | +4.7% | 0.00% | 0.0% |
| Q2 2020 | $490,000 | +32.1% | 20,064 | -20.0% | 0.00% | 0.0% |
| Q1 2020 | $371,000 | +4.8% | 25,091 | +14.9% | 0.00% | 0.0% |
| Q4 2019 | $354,000 | +64.7% | 21,838 | +32.3% | 0.00% | – |
| Q3 2019 | $215,000 | +4.9% | 16,508 | +4.6% | 0.00% | – |
| Q2 2019 | $205,000 | -4.2% | 15,775 | +15.9% | 0.00% | – |
| Q1 2019 | $214,000 | -21.9% | 13,606 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $274,000 | -11.3% | 13,606 | +9.4% | 0.00% | 0.0% |
| Q3 2018 | $309,000 | -9.4% | 12,433 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $341,000 | +6.6% | 12,433 | +19.6% | 0.00% | 0.0% |
| Q1 2018 | $320,000 | -14.0% | 10,392 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $372,000 | +30.1% | 10,392 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $286,000 | +4.4% | 10,392 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $274,000 | +35.6% | 10,392 | +75.5% | 0.00% | – |
| Q4 2015 | $202,000 | -16.5% | 5,920 | -21.9% | 0.00% | -100.0% |
| Q2 2015 | $242,000 | – | 7,579 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
| Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
| Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
| HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
| Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
| Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
| Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
| Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |